Sec. 1. Except as provided in section 8 of this chapter, a hospital or other health care facility may not interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin (laetrile) as an adjunct to recognized, customary, or accepted modes of therapy in the treatment of any malignancy, disease, illness, or physical condition if the following conditions exist:
(1) Amygdalin (laetrile) is prescribed or administered by a physician holding an unlimited license for the practice of medicine in Indiana.
(2) The patient has signed the "written informed request" as set forth in section 5 of this chapter.
[Pre-1993 Recodification Citation: 16-8-8-1.]
As added by P.L.2-1993, SEC.25.
Structure Indiana Code
Article 42. Regulation of Food, Drugs, and Cosmetics
Chapter 23. Drugs: Use of Amygdalin (Laetrile)
16-42-23-1. Health Care Facilities; Restrictions on Use
16-42-23-2. Disciplinary Action Against Attending Physician
16-42-23-3. Prescription or Administration Permitted With Written Informed Request
16-42-23-4. Construction of Chapter
16-42-23-5. Written Informed Request Form
16-42-23-6. Regulation of Use, Sale, Prescription, Manufacture, or Distribution Within State
16-42-23-7. Required Manufacture, Sale, Distribution, or Prescription